Liver Disease itself is the 5th leading cause of death in the UK for under 65s and the 2nd commonest cause of death in middle aged UK men; gloablly the WHO estimates it leads to 1-2 million deaths a year. Whilst a liver transplant is an effective way of managing conditions that cause acute and chronic liver failure, only 2 in 3 people on the transplant list in the UK get a new liver in time; given that 80% of those with acute liver failure will die without a transplant this is a huge problem.

The very nature of the liver provides us with an unique opportunity -given time it will regrow after acute damage. Thus, our solution - the bioartificial liver temporarily replaces liver function, giving the liver those critical few days necessary to heal itself. Our bioartificial liver “buys time” for a sick liver to repair itself in patients with acute liver failure; even in patients with chronic liver disease the bioartificial liver will buy them time until a new liver is available.